Anthony B. Evnin, Director at AVEO PHARMACEUTICALS INC (AVEO), sold 2,294,136 shares at $1.82 ($4.3M) on 2018-11-16, disclosed to the SEC on 2018-11-16.
Open-market sale of $4.3M AVEO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.90 | 325,139 | $618K | 14.4% |
| 2 | $1.90 | 325,139 | $618K | 14.4% |
| 3 | $1.86 | 670,894 | $1.2M | 29.1% |
| 4 | $1.86 | 670,894 | $1.2M | 29.1% |
| 5 | $1.82 | 151,035 | $275K | 6.4% |
| 6 | $1.82 | 151,035 |
| $275K |
| 6.4% |
| Total | $1.87 avg | 2,294,136 | $4.3M | 100% |
| Filing → |
| CNST | BUY | 2019-10-04 | $48.0M | — | Filing → |
| AVEO | BUY | 2018-11-26 | $223 | — | Filing → |
| CNST | BUY | 2018-07-23 | $2.0M | — | Filing → |